Literature DB >> 11179007

Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis.

K Göransdotter Ericson1, B Fadeel, S Nilsson-Ardnor, C Söderhäll, A Samuelsson, G Janka, M Schneider, A Gürgey, N Yalman, T Révész, R Egeler, K Jahnukainen, I Storm-Mathiesen, A Haraldsson , J Poole, G de Saint Basile, M Nordenskjöld, J Henter.   

Abstract

Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disease of early childhood characterized by nonmalignant accumulation and multivisceral infiltration of activated T lymphocytes and histiocytes (macrophages). Cytotoxic T and natural killer (NK) cell activity is markedly reduced or absent in these patients, and mutations in a lytic granule constituent, perforin, were recently identified in a number of FHL individuals. Here, we report a comprehensive survey of 34 additional patients with FHL for mutations in the coding region of the perforin gene and the relative frequency of perforin mutations in FHL. Perforin mutations were identified in 7 of the 34 families investigated. Six children were homozygous for the mutations, and one patient was a compound heterozygote. Four novel mutations were detected: one nonsense, two missense, and one deletion of one amino acid. In four families, a previously reported mutation at codon 374, causing a premature stop codon, was identified, and, therefore, this is the most common perforin mutation identified so far in FHL patients. We found perforin mutations in 20% of all FHL patients investigated (7/34), with a somewhat higher prevalence, approximately 30% (6/20), in children whose parents originated from Turkey. No other correlation between the type of mutation and the phenotype of the patients was evident from the present study. Our combined results from mutational analysis of 34 families and linkage analysis of a subset of consanguineous families indicate that perforin mutations account for 20%-40% of the FHL cases and the FHL 1 locus on chromosome 9 for approximately 10%, whereas the major part of the FHL cases are caused by mutations in not-yet-identified genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179007      PMCID: PMC1274472          DOI: 10.1086/318796

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

Review 1.  Perforin-mediated target cell lysis by cytolytic T lymphocytes.

Authors:  J Tschopp; M Nabholz
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans.

Authors:  M Yasukawa; H Ohminami; J Arai; Y Kasahara; Y Ishida; S Fujita
Journal:  Blood       Date:  2000-04-01       Impact factor: 22.113

3.  Structure and function of human perforin.

Authors:  M G Lichtenheld; K J Olsen; P Lu; D M Lowrey; A Hameed; H Hengartner; E R Podack
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

4.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

Authors:  S E Stepp; R Dufourcq-Lagelouse; F Le Deist; S Bhawan; S Certain; P A Mathew; J I Henter; M Bennett; A Fischer; G de Saint Basile; V Kumar
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

5.  Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis.

Authors:  M Aricò; L Nespoli; R Maccario; D Montagna; F Bonetti; D Caselli; G R Burgio
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

6.  Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH).

Authors:  G E Graham; L M Graham; P J Bridge; L D Maclaren; M J Coppes; R M Egeler
Journal:  Pediatr Res       Date:  2000-08       Impact factor: 3.756

7.  Molecular cloning and chromosomal assignment of a human perforin (PFP) gene.

Authors:  Y Shinkai; M C Yoshida; K Maeda; T Kobata; K Maruyama; J Yodoi; H Yagita; K Okumura
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

8.  Impaired natural killer activity in lymphohistiocytosis syndrome.

Authors:  N Perez; J L Virelizier; F Arenzana-Seisdedos; A Fischer; C Griscelli
Journal:  J Pediatr       Date:  1984-04       Impact factor: 4.406

Review 9.  Familial hemophagocytic lymphohistiocytosis.

Authors:  G E Janka
Journal:  Eur J Pediatr       Date:  1983 Jun-Jul       Impact factor: 3.183

10.  Structure of the human perforin gene. A simple gene organization with interesting potential regulatory sequences.

Authors:  M G Lichtenheld; E R Podack
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

View more
  50 in total

1.  Quantitative fluorescence measures for determination of intracellular perforin content.

Authors:  Kevin J Maher; Nancy G Klimas; Barry Hurwitz; Richard Schiff; Mary Ann Fletcher
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 2.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

3.  Accuracy of flow cytometric perforin screening for detecting patients with FHL due to PRF1 mutations.

Authors:  Manar Abdalgani; Alexandra H Filipovich; Sharon Choo; Kejian Zhang; Carrie Gifford; Joyce Villanueva; Jack J Bleesing; Rebecca A Marsh
Journal:  Blood       Date:  2015-10-08       Impact factor: 22.113

4.  Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis.

Authors:  Kimberly A Risma; Robert W Frayer; Alexandra H Filipovich; Janos Sumegi
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

5.  Reactive haemophagocytic lymphohistiocytosis.

Authors:  Shanto Pramanik; Priyankar Pal; P K Das; Subroto Chakrabarty; Arpita Bhattacharya; Sushmita Banerjee
Journal:  Indian J Pediatr       Date:  2009-04-16       Impact factor: 1.967

6.  A novel pathogenic variant in PRF1 associated with hemophagocytic lymphohistiocytosis.

Authors:  Camilo Andrés Pérez Romero; Isaura Pilar Sánchez; Sebastian Gutierrez-Hincapié; Jesús A Álvarez-Álvarez; Jaime Andres Pereañez; Rodrigo Ochoa; Carlos Enrique Muskus-López; Ruth G Eraso; Carolina Echeverry; Catalina Arango; José Luis Franco Restrepo; Claudia Milena Trujillo-Vargas
Journal:  J Clin Immunol       Date:  2015-05-15       Impact factor: 8.317

7.  Spectrum and clinical implications of syntaxin 11 gene mutations in familial haemophagocytic lymphohistiocytosis: association with disease-free remissions and haematopoietic malignancies.

Authors:  E Rudd; K Göransdotter Ericson; C Zheng; Z Uysal; A Ozkan; A Gürgey; B Fadeel; M Nordenskjöld; J-I Henter
Journal:  J Med Genet       Date:  2006-04       Impact factor: 6.318

8.  UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis.

Authors:  Hoi Soo Yoon; Hee-Jin Kim; Keon-Hee Yoo; Ki-Woong Sung; Hong-Hoe Koo; Hyoung Jin Kang; Hee Young Shin; Hyo Seop Ahn; Ji-Yoon Kim; Young-Tak Lim; Keun-Wook Bae; Ki-O Lee; Ji-Sook Shin; Seung-Tae Lee; Hae-Sun Chung; Sun-Hee Kim; Chan-Jeoung Park; Hyun-Sook Chi; Ho-Joon Im; Jong Jin Seo
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

9.  Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes.

Authors:  Kozo Nagai; Ken Yamamoto; Hiroshi Fujiwara; Jun An; Toshiki Ochi; Koichiro Suemori; Takahiro Yasumi; Hisamichi Tauchi; Katsuyoshi Koh; Maho Sato; Akira Morimoto; Toshio Heike; Eiichi Ishii; Masaki Yasukawa
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

Review 10.  Killing machines: three pore-forming proteins of the immune system.

Authors:  Ryan McCormack; Lesley de Armas; Motoaki Shiratsuchi; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.